Please use this identifier to cite or link to this item:
http://hdl.handle.net/10603/254206
Title: | Forced Degradation Study Of Selective H1Antihistaminic Drugs In Bulk And Formulation |
Researcher: | Shital Sukhabhai Patel |
Guide(s): | T Yunus Pasha |
Keywords: | H1-Antihistaminic drugs,Bilastine, Azelastine, Ebastine, HPLC, degradation kinetics, degradation products, HPLC, LC-MS/MS Physical Sciences,Chemistry,Chemistry Analytical |
University: | Gujarat Technological University |
Completed Date: | 07/08/2019 |
Abstract: | quotThe research study demonstrates development and validation of stability indicating HPLC methods for H1-Antihistaminic Drugs (Bilastine, Ebastine and Azelastine), degradation kinetic study; and identification of degradation products of selected drugs by LC-MS/MS study. Moreover, Literature review revealed that reported analytical methods are not adequate to monitor degradation kinetics and to demonstrate the degradation pattern of the drugs in various stress conditions. To estimate selected drugs stability indicating HPLC methods were developed and validated as per ICH guideline. Then they were extended to study degradation kinetics of drugs with different temperatures. newlineFurther degradation products were identified by LC-MS/MS data. The developed HPLC methods are accurate, precise, simple, sensitive and stability indicating and are suitable for routine analysis of drugs in their formulations. Order of degradation reaction was found. LC-MS/MS data confirms that in presence of hydrochloric acid, Bilastine reacts with methanol and produced methyl ester of Bilastine and on reaction with hydrogen peroxide Bilastine produces N-oxide of bilastine. LC-MS/MS study reveals that hydrochloric acid does the hydrolysis at ether linkage of Ebastine and Ebastine reacts with oxidizing agent, hydrogen peroxide and produces N-oxide of Ebastine. newlineThis PhD thesis would be useful for providing HPLC methods for routine analysis of selected drugs and they can be extended for bio-analysis of drugs.quot newline newline |
Pagination: | initial pages-xxivall pages end with page no.-149 |
URI: | http://hdl.handle.net/10603/254206 |
Appears in Departments: | Pharmacy |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
10_introduction.pdf | Attached File | 366.97 kB | Adobe PDF | View/Open |
11_literature review.pdf | 190.96 kB | Adobe PDF | View/Open | |
12_aim,objective and rationale.pdf | 146.92 kB | Adobe PDF | View/Open | |
13_chapter 4.pdf | 338.89 kB | Adobe PDF | View/Open | |
14_chapter 5.pdf | 241.34 kB | Adobe PDF | View/Open | |
15_chapter 6.pdf | 437.65 kB | Adobe PDF | View/Open | |
16_chapter 7.pdf | 309.4 kB | Adobe PDF | View/Open | |
17_chapter 7.pdf | 226.99 kB | Adobe PDF | View/Open | |
18_chapter 9.pdf | 401.61 kB | Adobe PDF | View/Open | |
19_chapter 10.pdf | 354.01 kB | Adobe PDF | View/Open | |
1_declaration.pdf | 55.53 kB | Adobe PDF | View/Open | |
1_title page.pdf | 56.96 kB | Adobe PDF | View/Open | |
20_chapter 11.pdf | 93.7 kB | Adobe PDF | View/Open | |
3_certificate.pdf | 51.48 kB | Adobe PDF | View/Open | |
4_abstract.pdf | 55.01 kB | Adobe PDF | View/Open | |
5_acknoledgement.pdf | 66.1 kB | Adobe PDF | View/Open | |
6_table of contents.pdf | 66.82 kB | Adobe PDF | View/Open | |
7_abbreviation.pdf | 62.66 kB | Adobe PDF | View/Open | |
8_list of figures.pdf | 70.19 kB | Adobe PDF | View/Open | |
9_list of tables.pdf | 65.98 kB | Adobe PDF | View/Open |
Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).
Altmetric Badge: